Open Medicine (Jun 2018)
MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease
Abstract
The aim of the study was to assess MMP-2 (matrix metalloproteinase-2) and TIMP-2 (tissue inhibitor of metalloproteinase-2) serum levels in patients with diverse types of heart failure (HF) and chronic kidney disease (CKD).
Keywords